Alejandro Noval is an experienced oncology consultant with over a decade of expertise in academic research and market insights. They earned a PhD in Oncology and Cancer Biology from Queen Mary University of London and have held several senior consulting positions, including their current role at Oracle. Alejandro's research background includes independent studies at Barts Cancer Institute, where they linked receptor trafficking to autophagy and hypoxia. With strong analytical, project management, and communication skills, they have contributed to various oncology and specialty therapeutics projects across multiple organizations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices